Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text










Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog
The race to develop combination vaccines - and the importance of indirect effects
July 8, 2024
Sponsored by:
Sponsor
Read blog
Health Economics & Outcomes Research (HEOR)
ICON
DNA & RNA
Cureline
Cell Culture & Characterization
HBS
PromoCell

Blog
PICO Predict by Decisive Consulting: An AI-enabled, Human-centred Approach to Preparing for EU-HTA
June 18, 2024
Read blog
No items found.
No items found.
Health Economics & Outcomes Research (HEOR)
PHAR
Blog
5 Considerations When Choosing a Raw Material Supplier for Your mRNA Program
June 13, 2024
Sponsored by:
Sponsor
Read blog
Chemical & Compound Analysis
Chemistry, Manufacturing & Controls
Raw Materials
TriLink BioTechnologies

Blog
Behind CellEDIT Service: The Experts Crafting Top-Quality Genetically Engineered Cell Lines for Researchers Worldwide
June 9, 2024
Read blog
DNA & RNA
No items found.

Blog
5 Things to Know About mRNA Capping for Next-Generation Vaccines and Therapies
May 22, 2024
Sponsored by:
Sponsor
Read blog
DNA & RNA
Chemistry, Manufacturing & Controls
Raw Materials
TriLink BioTechnologies

Blog
Unlocking the Potential of Large Language Models in Health Economics and Outcomes Research With Amaris
May 21, 2024
Read blog
Health Economics & Outcomes Research (HEOR)
No items found.
Antibodies
AvantGen
Disease Models
Instrumentation & Products
Satish R. Raj
Nasia Sheikh
Finapres Medical Systems
No items found.
Chemical & Compound Analysis
Björn Heitmann
Barbara Czarniecki
Bruker Corporation
No items found.
Disease Models
Jonas Treebak
Alexander Bartelt
Sable Systems International Inc.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Michael Broder
Jesse Ortendahl
PHAR
HealthEconomics.com
Disease Models
Sue Bodine
Aurora Scientific, Inc.
American Physiological Society
Alliance for Aging Research
Disease Models
Paul Marvar
Benjamin Turley
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
Steven Fountain
Sonya Snedecor
Sajjad Raza
PRECISIONheor
OPEN Health
PRMA Consulting
Scientist.com
Market Access
Medical Communications
Sajjad Raza
Steven Fountain
Sonya Snedecor
OPEN Health
PRECISIONheor
PRMA Consulting
Scientist.com
Disease Models
Stefano Gaburro
Brun Ulfhake
Tecniplast S.p.A.
American Physiological Society
Alliance for Aging Research
Disease Models
Aileen King
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Toxicology
Daniel Merriman
Femi Egbebi
Krzysztof Inglot
Thermo Fisher Scientific
No items found.
Pharmacology
Jonathan Nakashima
Grace Walton
Certis Oncology Solutions, Inc.
Hera BioLabs
Scientist.com
Disease Models
Rohan Jagirdar
Data Sciences International
Harvard Bioscience, Inc.
No items found.

Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)

Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)

Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM

Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences

.avif)


























.avif)






